Genomic instability and colon cancer

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Colorectal cancer (CRC) is a significant health issue, with 135,000 US cases and 57,000 deaths in 2001.
• CRC develops through accumulated genetic and epigenetic alterations in colonic epithelial cells.
• Loss of genomic stability is an early, critical step in tumorigenesis, creating an environment for oncogene and tumor suppressor gene alterations.

Purpose of the Study:

• To explore the role of genomic instability in colorectal cancer development.
• To identify and characterize different forms of genomic instability in colon cancer.
• To understand the mechanisms underlying genomic instability in colon cancer.

Main Methods:

• Identification and classification of genomic instability types in colon cancer.
• Analysis of microsatellite instability (MSI) mechanisms, including mismatch repair (MMR) system inactivation.
• Investigation of chromosome instability (CIN) causes, such as deregulation of DNA replication and mitotic checkpoints.

Main Results:

• Three major forms of genomic instability identified: MSI (approx. 15% of cases), CIN (majority of cases), and chromosomal translocations.
• MSI results from MMR deficiency, leading to mutations in genes like TGFBR2 and BAX.
• CIN is linked to checkpoint deregulation, with mutations in BUB1/BUBR1 and STK15 amplification found in some CIN colon cancers.

Conclusions:

• Genomic instability, particularly MSI and CIN, is central to colon cancer pathogenesis.
• Understanding the mechanisms of genomic instability may lead to targeted therapies.
• Further research is needed to elucidate the causes of CIN in unexplained cases and to develop effective chemotherapy strategies.